Claude Ranoux Sells 100,000 Shares of Invo Bioscience Inc (IVOB) Stock

Invo Bioscience Inc (OTCMKTS:IVOB) major shareholder Claude Ranoux sold 100,000 shares of Invo Bioscience stock in a transaction on Monday, January 8th. The shares were sold at an average price of $0.13, for a total transaction of $13,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Claude Ranoux also recently made the following trade(s):

  • On Thursday, January 4th, Claude Ranoux sold 2,834 shares of Invo Bioscience stock. The shares were sold at an average price of $0.15, for a total transaction of $425.10.
  • On Friday, December 29th, Claude Ranoux sold 4,525 shares of Invo Bioscience stock. The shares were sold at an average price of $0.16, for a total transaction of $724.00.
  • On Wednesday, December 27th, Claude Ranoux sold 10,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.17, for a total transaction of $1,700.00.
  • On Wednesday, December 20th, Claude Ranoux sold 10,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.17, for a total transaction of $1,700.00.
  • On Monday, December 18th, Claude Ranoux sold 30,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.17, for a total transaction of $5,100.00.
  • On Monday, December 11th, Claude Ranoux sold 50,000 shares of Invo Bioscience stock. The stock was sold at an average price of $0.18, for a total transaction of $9,000.00.

Invo Bioscience Inc (OTCMKTS:IVOB) opened at $0.15 on Thursday. The firm has a market cap of $21.25, a price-to-earnings ratio of -15.00 and a beta of 1.72. The company has a current ratio of 0.03, a quick ratio of 0.02 and a debt-to-equity ratio of -0.03. Invo Bioscience Inc has a 52-week low of $0.08 and a 52-week high of $0.40.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/11/claude-ranoux-sells-100000-shares-of-invo-bioscience-inc-ivob-stock.html.

Invo Bioscience Company Profile

INVO Bioscience, Inc is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company’s product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC).

Receive News & Ratings for Invo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply